<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39374775</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-0849</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>05</Day></PubDate></JournalIssue><Title>European journal of medical genetics</Title><ISOAbbreviation>Eur J Med Genet</ISOAbbreviation></Journal><ArticleTitle>Telehealth for rare disease care, research, and education across the globe: A review of the literature by the IRDiRC telehealth task force.</ArticleTitle><Pagination><StartPage>104977</StartPage><MedlinePgn>104977</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejmg.2024.104977</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1769-7212(24)00069-7</ELocationID><Abstract><AbstractText>The International Rare Diseases Research Consortium (IRDiRC) Telehealth (TH) Task Force explored the use of TH for improving diagnosis, care, research, and education for rare diseases (RDs). The Task Force reviewed related literature published from January 2017 to August 2023, and identified various models and implementation strategies of TH for RD. The Task Force highlighted the reported value and benefits of using TH for RDs, along with the limitations and opportunities. The number of publications sharply increased since 2021, coinciding with the onset of the COVID-19 pandemic, which forced the rapid adoption of TH in many healthcare settings. One of the major benefits of TH for RDs lies in its capacity to surmount geographical barriers, which helps in overcoming the constraints posed by limited numbers and geographical dispersion of specialists. This was evident during the pandemic when TH was used to maintain a level of continued medical care and research when face-to-face visits were severely restricted. TH, through which clinical research can be decentralized, can also facilitate and enhance RD research by decreasing burden, expanding access, and enhancing efficiency. This will be especially beneficial when coupled with the adoption of digital health technologies, such as mobile health (mHealth) and wearable devices for remote monitoring (i.e., surveillance of outpatient data transmitted through devices), along with big data solutions. TH has also been shown to be an effective means for RD education and peer mentoring, enabling local health care providers (HCPs) to care for RD patients, which indirectly ensures that RD patients get the expertise and multidisciplinary care they need. However, limitations and weaknesses associated with using TH for RD care and research were also identified, including the inability to perform physical examinations and build relationships with HCPs. Therefore, TH has been recommended as a complement to, rather than substitute for, face-to-face consultations. There is also a concern that TH may lead to an amplification of health disparities and inequities related to social determinants of health for those with RDs due to lack of access to TH technologies, inadequate digital literacy, and geographical, socio-cultural, and linguistic barriers. Finally, the Task Force also discussed evidence and knowledge gaps that will benefit from future research efforts to help advance and expand the use of TH for RD care, research, and education.</AbstractText><CopyrightInformation>Copyright © 2024. Published by Elsevier Masson SAS.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Faye H</ForeName><Initials>FH</Initials><AffiliationInfo><Affiliation>National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), USA. Electronic address: chenf1@mail.nih.gov.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartman</LastName><ForeName>Adam L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Letinturier</LastName><ForeName>Mary Catherine V</ForeName><Initials>MCV</Initials><AffiliationInfo><Affiliation>IRDiRC Scientific Secretariat, French National Institute of Health and Medical Research (Inserm), France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antoniadou</LastName><ForeName>Victoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Cyprus Alliance for Rare Disorders, Nicosia, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baynam</LastName><ForeName>Gareth</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Rare Care Centre, Perth Children's Hospital and Western Australian Register of Developmental Anomalies, King Edward Memorial Hospital, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bloom</LastName><ForeName>Lara</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Ehlers-Danlos Society, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crimi</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Kaleidos SCS, Scientific Office, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Della Rocca</LastName><ForeName>Maria G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Global Genes, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Didato</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Epilepsy Unit, Sleep Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Houge</LastName><ForeName>Sofia Douzgou</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonker</LastName><ForeName>Anneliene</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Twente, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawome</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sally Mugabe Central Hospital, Zimbabwe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mueller</LastName><ForeName>Friederike</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Child and Youth Psychiatry, Psychosomatics and Psychotherapy, Asklepios Hospital Luebben, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Brien</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>International Prader Willi Syndrome Organisation (IPWSO), United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puri</LastName><ForeName>Ratna Dua</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Institute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Nuala</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>NCBRS (Nicolaides-Baraitser Syndrome) Worldwide Foundation, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thong</LastName><ForeName>Meow-Keong</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Genetics and Metabolism Unit, Department of Paediatrics, Faculty of Medicine, University of Malaya, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tumienė</LastName><ForeName>Birutė</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Vilnius University, Faculty of Medicine, Institute of Biomedical Sciences, Vilnius University Hospital Santaros Klinikos, Lithuania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parisi</LastName><ForeName>Melissa A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Eur J Med Genet</MedlineTA><NlmUniqueID>101247089</NlmUniqueID><ISSNLinking>1769-7212</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Decentralized clinical trial</Keyword><Keyword MajorTopicYN="N">IRDiRC</Keyword><Keyword MajorTopicYN="N">Peer mentoring</Keyword><Keyword MajorTopicYN="N">Rare disease</Keyword><Keyword MajorTopicYN="N">Rare disease care</Keyword><Keyword MajorTopicYN="N">Rare disease education</Keyword><Keyword MajorTopicYN="N">Rare disease research</Keyword><Keyword MajorTopicYN="N">Remote monitoring</Keyword><Keyword MajorTopicYN="N">Telehealth</Keyword><Keyword MajorTopicYN="N">Telemedicine</Keyword><Keyword MajorTopicYN="N">eHealth</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39374775</ArticleId><ArticleId IdType="doi">10.1016/j.ejmg.2024.104977</ArticleId><ArticleId IdType="pii">S1769-7212(24)00069-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle>